Accord Healthcare, Inc.: Levothyroxine Sodium Tablets, Usp, 300 Mcg (0.3mg), 90 Tablets Bottles
Levothyroxine Recall Summary Accord Healthcare is recalling Levothyroxine Sodium Tablets (300 mcg, 90-tablet bottles) nationwide because the medication is subpotent—meaning it contains less active ingredient than it should. This thyroid medication was distributed across all U.S. states and the District of Columbia. The recall affects anyone who received this specific product (NDC 16729-458-15).
- Recalling firm
- ACCORD HEALTHCARE, INC.
- Product
- Levothyroxine Sodium Tablets, USP, 300 mcg (0.3mg), 90 Tablets bottles, Rx only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: lntas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, INDIA, NDC 16729-458-15.
- Reason
- Subpotent Drug
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-06-08
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- US Nationwide.
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/24504757-cedc-4d7b-aa8e-208905c41167